Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2-HOBA in Salt Sensitivity of Blood Pressure
NCT07602166Phase 2Recruiting
- Sponsor
- Vanderbilt University Medical Center
- Start
- Oct 2026
- Primary completion
- Jul 2031
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of 2-hydroxybenzylamine in hypertension (HTN), sponsored by Vanderbilt University Medical Center. Started Oct 2026; status: recruiting.
02
Drugs
2-hydroxybenzylamine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT07602166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07602166.